Iluzanebart is a monoclonal antibody commercialized by Vigil Neuroscience, with a leading Phase III program in Neurodegenerative Diseases.

Matthew Nace, the couple’s attorney, also did not return a request for comment. The complaint states Czwartacki potentially showed signs of progressive multifocal leukoencephalopathy during treatment, ...

Ocrevus Treatment For Multiple Sclerosis. Ocrevus, also known by its generic name ocrelizumab, is an immunotherapy drug ...

It’s rare for medical research to be truly ‘groundbreaking’, but the case study from China showing that stem cell therapy can reverse type 1 diabetes is worthy of this adjective.

Progressive multifocal leukoencephalopathy (PML) is a rare but serious brain infection. It gradually destroys brain tissue ...